We are live on
!
Find out more
AAM
AMI Asset Management Portfolio holdings
AUM
$1.57B
1-Year Est. Return
19.49%
This Fund
S&P 500
This Quarter
Est. Return
+29.08%
1 Year Est. Return
+19.49%
3 Year Est. Return
+63.87%
5 Year Est. Return
+88.87%
10 Year Est. Return
+403.39%
AUM
$1.88B
AUM Growth
+$291M
(+18%)
Cap. Flow
-$118M
Cap. Flow
% of AUM
-6.28%
Top 10 Holdings %
Top 10 Hldgs %
34.86%
Holding
85
New
7
Increased
17
Reduced
56
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$19.1M |
| 2 |
Nike
NKE
|
+$14.6M |
| 3 |
Teleflex
TFX
|
+$12M |
| 4 |
Halozyme
HALO
|
+$11.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$10.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadridge
BR
|
+$46.7M |
| 2 |
PayPal
PYPL
|
+$21.8M |
| 3 |
Adobe
ADBE
|
+$19.7M |
| 4 |
West Pharmaceutical
WST
|
+$17.8M |
| 5 |
QuidelOrtho
QDEL
|
+$9.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Healthcare | 19.55% |
| 3 | Consumer Staples | 17.18% |
| 4 | Consumer Discretionary | 14.31% |
| 5 | Financials | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.9T
| $92.1M | 4.91% |
1,009,712
-111,892
| -10% | -$8.67M |
|
2
Microsoft
MSFT
$2.93T
| $90.8M | 4.84% |
446,203
-47,895
| -10% | -$8.69M |
|
3
Salesforce
CRM
$140B
| $60.6M | 3.23% |
323,634
-21,035
| -6% | -$3.54M |
|
4
Amazon
AMZN
$2.66T
| $60.6M | 3.23% |
439,240
-13,940
| -3% | -$1.68M |
|
5
Mastercard
MA
$480B
| $59.8M | 3.19% |
202,391
-13,747
| -6% | -$3.88M |
|
6
Alphabet (Google) Class A
GOOGL
$4.23T
| $59.4M | 3.17% |
837,240
-65,020
| -7% | -$4.38M |
|
7
Church & Dwight Co
CHD
$23.2B
| $59.2M | 3.16% |
766,239
-60,538
| -7% | -$4.4M |
|
8
Becton Dickinson
BDX
$43.6B
| $58M | 3.09% |
248,592
-18,934
| -7% | -$4.56M |
|
9
PepsiCo
PEP
$187B
| $56.7M | 3.03% |
429,005
-32,826
| -7% | -$4.33M |
|
|
10
PayPal
PYPL
$49.9B
| $56.4M | 3.01% |
323,582
-157,412
| -33% | -$21.8M |
|
11
Labcorp
LH
$23.2B
| $56.3M | 3% |
394,328
-25,966
| -6% | -$3.59M |
|
12
Zoetis
ZTS
$32.1B
| $56M | 2.99% |
408,951
-31,569
| -7% | -$4.12M |
|
13
Ball Corp
BALL
$16.7B
| $53.8M | 2.87% |
774,106
-51,869
| -6% | -$3.51M |
|
14
McCormick & Company Non-Voting
MKC
$13.9B
| $51.3M | 2.74% |
572,134
-43,710
| -7% | -$3.6M |
|
|
15
Adobe
ADBE
$94.3B
| $48.7M | 2.6% |
111,854
-53,248
| -32% | -$19.7M |
|
16
Waste Management
WM
$96.1B
| $47.1M | 2.51% |
444,655
-31,604
| -7% | -$3.19M |
|
17
Costco
COST
$417B
| $45.8M | 2.44% |
151,152
-11,418
| -7% | -$3.47M |
|
18
Avery Dennison
AVY
$12.3B
| $45.5M | 2.43% |
399,143
-31,184
| -7% | -$3.43M |
|
|
SCHW
19
Charles Schwab
SCHW
$177B
| $44.7M | 2.38% |
1,323,914
+190,640
| +17% | +$6.83M |
|
|
20
Teleflex
TFX
$5.96B
| $44.7M | 2.38% |
122,673
+34,832
| +40% | +$12M |
|
|
KSU
21
DELISTED
Kansas City Southern
KSU
| $43.5M | 2.32% |
291,522
+44,559
| +18% | +$6.26M |
|
|
HZNP
22
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $41.7M | 2.22% |
750,157
+446,999
| +147% | +$19.1M |
|
23
Constellation Brands
STZ
$22.7B
| $41.6M | 2.22% |
237,536
-15,427
| -6% | -$2.57M |
|
|
24
Meta Platforms (Facebook)
META
$1.64T
| $40.3M | 2.15% |
177,348
+49,749
| +39% | +$10.4M |
|
25
Synopsys
SNPS
$73.6B
| $39.4M | 2.1% |
202,264
-15,451
| -7% | -$2.55M |
|
Similar funds
GL
APF
FCM
BFIM
FDCP
CWG
1WM
AC
AMI Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, AMI Asset Management held 85 positions worth $1.88B, up 18% from $1.58B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
AMI Asset Management withdrew a net $118M in Q2 2020, closing 4 positions and reducing 56 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $2.97M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, AMI Asset Management opened a new position in Halozyme worth $14.1M.
- AMI Asset Management's largest Q2 2020 buy was Halozyme: 526,389 shares worth $14.1M.
- AMI Asset Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020, an estimated $19.1M increase.
- AMI Asset Management's biggest Q2 2020 reduction was Broadridge, cutting an estimated $46.7M.
- AMI Asset Management fully exited iShares Russell 1000 Growth ETF in Q2 2020, selling an estimated $2.97M.
- AMI Asset Management's ten largest holdings make up 35% of its $1.88B portfolio in Q2 2020.
- AMI Asset Management opened 7 new positions and closed 4 in Q2 2020.
- AMI Asset Management's portfolio value rose 18% quarter-over-quarter to $1.88B.
Based on AMI Asset Management's 13F filing for Q2 2020, filed 15 Jul 2020.